• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯 COPD 的患病率、发病率、发病率和死亡率:1990 年至 2019 年 COPD 负担趋势。

Prevalence, incidence, morbidity and mortality rates of COPD in Saudi Arabia: Trends in burden of COPD from 1990 to 2019.

机构信息

Department of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia.

Head of Scientific Research and Publication Department, Vice Deanship of Postgraduate Studies and Research, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia.

出版信息

PLoS One. 2022 May 19;17(5):e0268772. doi: 10.1371/journal.pone.0268772. eCollection 2022.

DOI:10.1371/journal.pone.0268772
PMID:35588429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9119447/
Abstract

BACKGROUND

The available data to determine the chronic obstructive pulmonary disease (COPD) burden in Saudi Arabia are scarce. Therefore, this study closely examines and tracks the trends of the COPD burden in Saudi Arabia from 1990 to 2019 using the dataset of the Global Burden of Disease (GBD) 2019.

METHODS

This study used the GBD 2019 dataset to analyse the COPD prevalence, incidence, morbidity and mortality rates in the Saudi Arabian population from 1990 to 2019, stratified by sex and age. The age-standardised rate was used to determine the prevalence, incidence, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life years (DALYs) and deaths.

RESULTS

In 2019, an estimated 434,560.64 people (95% Uncertainty Interval (UI) 396,011.72-473,596.71) had COPD in Saudi Arabia, corresponding to an increase of 329.82% compared with the number of diagnosed people in 1990 [101,104.05 (95% UI 91,334.4-111,223.91)]. The prevalence rate of COPD increased by 49%, from 1,381.26 (1,285.35-1,484.96) cases per 100,000 in 1990 to 2,053.04 (1918.06-2194.29) cases per 100,000 in 2019, and this trend was higher in males than females. The incidence rate of COPD in 2019 was 145.06 (136.62-154.76) new cases per 100,000, representing an increase of 43.4% from the 1990 incidence rate [101.18 (95.27-107.86)]. In 2019, the DALYs rate was 508.15 (95% UI 434.85-581.58) per 100,000 population. This was higher in males than females, with a 14.12% increase among males. In 2019, YLLs contributed to 63.6% of DALYs due to COPD. The death rate due to COPD was 19.6 (95% UI 15.94-23.39) deaths per 100 000 in 2019, indicating a decrease of 41.44% compared with the death rate in 1990 [33.55 deaths per 100 000 (95% UI 25.13-47.69)]. In 2019, COPD deaths accounted for 1.65% (1.39-1.88) of the total of deaths in Saudi Arabia and 57% of all deaths caused by chronic respiratory diseases.

CONCLUSION

Over the period 1990-2019, the prevalence and incidence of COPD in Saudi Arabia have been steadily rising. Even though COPD morbidity and death rates have been decreasing, they remain higher in men and older age. The holistic assessment and interventions with careful attention to optimising the community-based primary care management, such as screening for early diagnosis, smoking cessation programs and pulmonary rehabilitation, are likely to be the most successful strategies to reduce the burden of COPD in Saudi Arabia.

摘要

背景

目前,用于确定沙特阿拉伯地区慢性阻塞性肺疾病(COPD)负担的数据有限。因此,本研究利用 2019 年全球疾病负担(GBD)研究的数据,对 1990 年至 2019 年期间沙特阿拉伯 COPD 负担的趋势进行了深入研究。

方法

本研究使用 2019 年 GBD 数据,按性别和年龄对沙特阿拉伯人群的 COPD 患病率、发病率、发病率和死亡率进行了分析。使用年龄标准化率来确定患病率、发病率、生命损失年数(YLL)、失能生命年数(YLD)、残疾调整生命年数(DALY)和死亡人数。

结果

2019 年,沙特阿拉伯有 434560.64 人(95%不确定区间[UI]396011.72-473596.71)患有 COPD,与 1990 年诊断出的人数相比,增加了 329.82%[101104.05(95%UI 91334.4-111223.91)]。COPD 的患病率增加了 49%,从 1990 年的每 100000 人 1381.26 例(1285.35-1484.96)上升到 2019 年的每 100000 人 2053.04 例(1918.06-2194.29),这一趋势在男性中比女性更为明显。2019 年 COPD 的发病率为每 100000 人 145.06 例(136.62-154.76)新发病例,比 1990 年的发病率增加了 43.4%[101.18(95.27-107.86)]。2019 年,DALY 率为每 100000 人 508.15(95%UI 434.85-581.58)。男性的这一比率高于女性,男性增加了 14.12%。2019 年,由于 COPD,YLL 占 DALY 的 63.6%。2019 年,由于 COPD 导致的死亡率为每 100000 人 19.6(95%UI 15.94-23.39),与 1990 年相比下降了 41.44%[33.55 人/每 100000 人(95%UI 25.13-47.69)]。2019 年,由于 COPD 导致的死亡占沙特阿拉伯总死亡人数的 1.65%(1.39-1.88),占所有慢性呼吸道疾病死亡人数的 57%。

结论

1990 年至 2019 年期间,沙特阿拉伯的 COPD 患病率和发病率一直在稳步上升。尽管 COPD 的发病率和死亡率一直在下降,但在男性和老年人中仍较高。全面评估并采取干预措施,密切关注优化基于社区的初级保健管理,如早期诊断筛查、戒烟计划和肺康复等,可能是减轻沙特阿拉伯 COPD 负担的最成功策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/c8a0f92a9b16/pone.0268772.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/bff57bca7a53/pone.0268772.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/1e095ff819a8/pone.0268772.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/1b14b3f0bd9b/pone.0268772.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/e42a8c347133/pone.0268772.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/be230c24fc93/pone.0268772.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/48ecb1cd0770/pone.0268772.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/0e5758bf5111/pone.0268772.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/c8a0f92a9b16/pone.0268772.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/bff57bca7a53/pone.0268772.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/1e095ff819a8/pone.0268772.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/1b14b3f0bd9b/pone.0268772.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/e42a8c347133/pone.0268772.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/be230c24fc93/pone.0268772.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/48ecb1cd0770/pone.0268772.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/0e5758bf5111/pone.0268772.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0260/9119447/c8a0f92a9b16/pone.0268772.g008.jpg

相似文献

1
Prevalence, incidence, morbidity and mortality rates of COPD in Saudi Arabia: Trends in burden of COPD from 1990 to 2019.沙特阿拉伯 COPD 的患病率、发病率、发病率和死亡率:1990 年至 2019 年 COPD 负担趋势。
PLoS One. 2022 May 19;17(5):e0268772. doi: 10.1371/journal.pone.0268772. eCollection 2022.
2
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.全球、地区和国家慢性阻塞性肺疾病和哮喘的死亡、患病率、残疾调整生命年以及与残疾相关的生命年,1990-2015 年:2015 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16.
3
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家 204 个地区 1990-2019 年 12 种精神障碍疾病的负担:基于 2019 年全球疾病负担研究的系统分析。
Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10.
4
Burden of COPD in Nepal.尼泊尔慢性阻塞性肺疾病的负担。
Int J Chron Obstruct Pulmon Dis. 2018 Feb 9;13:583-589. doi: 10.2147/COPD.S154319. eCollection 2018.
5
Ambient particulate matter burden of disease in the Kingdom of Saudi Arabia.沙特阿拉伯王国的环境颗粒物疾病负担。
Environ Res. 2021 Jun;197:111036. doi: 10.1016/j.envres.2021.111036. Epub 2021 Mar 26.
6
The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016.印度各邦慢性呼吸道疾病负担及其异质性:1990-2016 年全球疾病负担研究。
Lancet Glob Health. 2018 Dec;6(12):e1363-e1374. doi: 10.1016/S2214-109X(18)30409-1. Epub 2018 Sep 12.
7
The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019.中国及各省 COPD 负担:来自 2019 年全球疾病负担研究的发现。
Front Public Health. 2022 Jun 3;10:859499. doi: 10.3389/fpubh.2022.859499. eCollection 2022.
8
Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013.中风发病率、患病率、死亡率及伤残调整生命年的性别差异:全球疾病负担研究2013结果
Neuroepidemiology. 2015;45(3):203-14. doi: 10.1159/000441103. Epub 2015 Oct 28.
9
Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0-19 Years: Data from the Global and Regional Burden of Stroke 2013.儿童和青少年(0-19 岁)中的卒中发生率、死亡率和伤残调整生命年:来自全球和区域卒中负担 2013 的数据。
Neuroepidemiology. 2015;45(3):177-89. doi: 10.1159/000441087. Epub 2015 Oct 28.
10
Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016.全球 2016 年因非传染性空气传播职业暴露导致的慢性呼吸道疾病负担:2016 年全球疾病负担研究的系统分析。
Occup Environ Med. 2020 Mar;77(3):142-150. doi: 10.1136/oemed-2019-106013.

引用本文的文献

1
Long-Term Efficacy of Novel and Traditional Home-Based, Remote Inspiratory Muscle Training in COPD: A Randomized Controlled Trial.新型与传统居家远程吸气肌训练对慢性阻塞性肺疾病的长期疗效:一项随机对照试验
J Clin Med. 2025 Aug 28;14(17):6099. doi: 10.3390/jcm14176099.
2
Up in smoke: Identifying signs, symptoms, and risk factors of lung cancer among smokers in Saudi Arabia.化为乌有:识别沙特阿拉伯吸烟者中肺癌的体征、症状和风险因素。
Ann Thorac Med. 2025 Jul-Sep;20(3):169-175. doi: 10.4103/atm.atm_224_24. Epub 2025 Feb 10.
3
The Association Between Medication Adherence and Health-Related Quality of Life in Patients with COPD: A Cross-Sectional Study.

本文引用的文献

1
Pulmonary rehabilitation for COPD: A narrative review and call for further implementation in Saudi Arabia.慢性阻塞性肺疾病的肺康复:一项叙述性综述及在沙特阿拉伯进一步实施的呼吁。
Ann Thorac Med. 2021 Oct-Dec;16(4):299-305. doi: 10.4103/atm.atm_639_20. Epub 2021 Oct 26.
2
Unmet need in the management of chronic obstructive pulmonary disease in the Middle East and Africa region: An expert panel consensus.中东和非洲地区慢性阻塞性肺疾病管理中的未满足需求:专家小组共识。
Respir Med. 2021 Nov-Dec;189:106641. doi: 10.1016/j.rmed.2021.106641. Epub 2021 Oct 5.
3
Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis.
慢性阻塞性肺疾病患者药物依从性与健康相关生活质量的关联:一项横断面研究。
Int J Chron Obstruct Pulmon Dis. 2025 May 21;20:1567-1583. doi: 10.2147/COPD.S509949. eCollection 2025.
4
Optimizing Pulmonary Rehabilitation in Saudi Arabia: Current Practices, Challenges, and Future Directions.优化沙特阿拉伯的肺康复:当前实践、挑战及未来方向。
Medicina (Kaunas). 2025 Apr 6;61(4):673. doi: 10.3390/medicina61040673.
5
Awareness and barriers of adherence to chronic obstructive pulmonary disease guidelines among respiratory therapists.呼吸治疗师对慢性阻塞性肺疾病指南的依从性认知及障碍
Ann Thorac Med. 2025 Apr-Jun;20(2):108-116. doi: 10.4103/atm.atm_227_24. Epub 2025 Mar 31.
6
Knowledge, Attitudes, and Practices of Healthcare Providers Towards Advance Directive for COPD Patients in Riyadh, Saudi Arabia.沙特阿拉伯利雅得医疗服务提供者对慢性阻塞性肺疾病(COPD)患者预立医疗指示的认知、态度和实践
Healthcare (Basel). 2025 Mar 30;13(7):771. doi: 10.3390/healthcare13070771.
7
Mapping the Global distribution, risk factors, and temporal trends of COPD incidence and mortality (1990-2021): ecological analysis.绘制慢性阻塞性肺疾病发病率和死亡率的全球分布、风险因素及时间趋势(1990 - 2021年):生态分析
BMC Med. 2025 Apr 7;23(1):210. doi: 10.1186/s12916-025-04014-0.
8
Fisetin Mitigates Chronic Lung Injury Induced by Benzo(a)Pyrene by Regulation of Inflammation and Oxidative Stress.漆黄素通过调节炎症和氧化应激减轻苯并(a)芘诱导的慢性肺损伤。
Curr Issues Mol Biol. 2025 Mar 19;47(3):209. doi: 10.3390/cimb47030209.
9
Temporal trends, gender, and ethnoracial disparities in mortality from pulmonary emphysema: A retrospective nationwide analysis.肺气肿死亡率的时间趋势、性别及种族差异:一项全国性回顾分析
Medicine (Baltimore). 2024 Dec 27;103(52):e41032. doi: 10.1097/MD.0000000000041032.
10
Hematological Parameters Predicting Mortality in Patients with COPD Admitted to ICUs.预测入住重症监护病房的慢性阻塞性肺疾病患者死亡率的血液学参数
Saudi J Med Med Sci. 2025 Jan-Mar;13(1):26-31. doi: 10.4103/sjmms.sjmms_276_24. Epub 2025 Jan 11.
在 COVID-19 期间减少住院 COPD 加重:系统评价和荟萃分析。
PLoS One. 2021 Aug 3;16(8):e0255659. doi: 10.1371/journal.pone.0255659. eCollection 2021.
4
Research priorities for exacerbations of COPD.慢性阻塞性肺疾病急性加重的研究重点
Lancet Respir Med. 2021 Aug;9(8):824-826. doi: 10.1016/S2213-2600(21)00227-7. Epub 2021 May 14.
5
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
6
Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis.慢性阻塞性肺疾病恶化后全因住院再入院的危险因素:系统评价和荟萃分析。
Eur Respir Rev. 2020 Jun 3;29(156). doi: 10.1183/16000617.0166-2019. Print 2020 Jun 30.
7
The burden of disease in Saudi Arabia 1990-2017: results from the Global Burden of Disease Study 2017.《1990-2017 年沙特阿拉伯疾病负担:2017 年全球疾病负担研究结果》
Lancet Planet Health. 2020 May;4(5):e195-e208. doi: 10.1016/S2542-5196(20)30075-9.
8
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.COPD 与 COVID-19 患者吸烟的流行率、严重程度和死亡率:一项快速系统评价和荟萃分析。
PLoS One. 2020 May 11;15(5):e0233147. doi: 10.1371/journal.pone.0233147. eCollection 2020.
9
Factors influencing management of chronic respiratory diseases in general and chronic obstructive pulmonary disease in particular in Saudi Arabia: An overview.沙特阿拉伯慢性呼吸道疾病总体管理尤其是慢性阻塞性肺疾病管理的影响因素:概述
Ann Thorac Med. 2018 Jul-Sep;13(3):144-149. doi: 10.4103/atm.ATM_293_17.
10
The unmet global burden of COPD.慢性阻塞性肺疾病未被满足的全球负担。
Glob Health Epidemiol Genom. 2018 Apr 6;3:e4. doi: 10.1017/gheg.2018.1. eCollection 2018.